Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
GlobeStar Therapeutics Corporation (GSTC) had Non-Operating Income/Expense of $-0.00M for the most recently reported fiscal quarter, ending 2024-06-30.
| Income Statement Financials | |
-- |
|
$-0.20M |
|
-- |
|
-- |
|
$0.19M |
|
$-0.19M |
|
|
Non-Operating Income/Expense |
$-0.00M |
$-0.20M |
|
$-0.20M |
|
$-0.20M |
|
$-0.20M |
|
$-0.20M |
|
$-0.20M |
|
$-0.19M |
|
$-0.19M |
|
1.21B |
|
1.21B |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$0.08M |
|
-- |
|
-- |
|
$0.08M |
|
$1.71M |
|
-- |
|
-- |
|
$1.71M |
|
$-1.63M |
|
$-1.62M |
|
$-1.62M |
|
1.24B |
|
| Cash Flow Statement Financials | |
$-0.08M |
|
-- |
|
$0.08M |
|
-- |
|
$0.00M |
|
$0.00M |
|
$0.04M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.05 |
|
-- |
|
-- |
|
-- |
|
-0.20 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.08M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
12.16% |
|
12.16% |
|
-235.66% |
|
12.16% |
|
$-0.00 |
|
$-0.00 |
|
$-0.00 |
|